BioCentury
ARTICLE | Financial News

Alphamab Oncology sets sights on $220M IPO as HKSE continues to gain momentum

December 3, 2019 12:53 AM UTC

Alphamab Oncology is aiming to raise about HK$1.7 billion ($221.1 million) in an IPO on the Hong Kong stock exchange next week in an offering that would value the company at HK$8.7 billion if priced at the midpoint of the proposed range.

The pre-profit company proposed to sell 179.4 million shares at HK$9.10-HK$10.20 on the exchange’s biotech chapter...